App and resistance bands aim to boost recovery in esophageal cancer survivors

NCT ID NCT07180134

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a health informatics platform (with educational videos and instant messaging) plus resistance band exercises can improve quality of life and reduce muscle loss in 90 people who have had surgery for esophageal cancer. Participants will either receive the 12-week program or standard care. The goal is to see if this approach helps with recovery and daily functioning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

health informatics platform plus resistance band exercise

What this could lead to

If it works, this could offer a practical, home-based program to help esophageal cancer survivors feel better and regain strength after surgery.

What could go wrong

This is a small, early-stage study (90 people) testing a behavioral intervention, not a drug. Results may not apply to everyone, and the program requires commitment to exercise and messaging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms Motor Activity Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••